Parallax Volatility Advisers
EPZM

Parallax Volatility Advisers’s Epizyme, Inc EPZM Stock Holding History

Parallax Volatility Advisers’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-51,400
Closed -$427K – 3621
2021
Q2 		$427K Hold
51,400
– – ﹤0.01% 2243
2021
Q1 		$448K Hold
51,400
– – ﹤0.01% 2424
2020
Q4 		$558K Buy
+51,400
New +$634K ﹤0.01% 2441

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Parallax Volatility Advisers's EPZM Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Epizyme, Inc (EPZM) in Q3 2021, closing a stake of 44,591 shares — an estimated $371K sold.

Parallax Volatility Advisers first reported a position in EPZM in Q4 2017 and held it in 5 quarters. The position peaked at $371K in Q2 2021. 116 funds tracked by Wall St. Rank hold EPZM as of Q3 2021.

  • Parallax Volatility Advisers reported no remaining Epizyme, Inc position as of Q3 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 44,591 Epizyme, Inc shares in Q3 2021, an estimated $371K.
  • Parallax Volatility Advisers first reported a position in Epizyme, Inc in Q4 2017 and held it in 5 quarters.
  • Parallax Volatility Advisers's Epizyme, Inc position peaked at $371K in Q2 2021.
  • 116 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.